Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 3—March 2008
Research

Epidemiology of Nontuberculous Mycobacteria in Patients without HIV Infection, New York City

Ethan E. Bodle*, Jennifer A. Cunningham*, Phyllis Della-Latta*, Neil W. Schluger*, and Lisa Saiman*Comments to Author 
Author affiliations: *Columbia University, New York, New York, USA;

Main Article

Table 2

Site of disease and species of nontuberculous mycobacteria, New York–Presbyterian Hospital, Columbia University Medical Center, New York, New York, 2000–2003*

Site of disease No. patients with MAC infection No. patients with RGM infection No. patients with other species infections Total no. patients (%)
Respiratory tract 65 7 9 81 (68.1)
Skin and soft tissue, nonsurgical 2 4 6 12 (10.1)
Surgical sites 0 7 2 9 (7.6)
Bloodstream 2 4 1 7 (5.9)
Lymph node 5 1 0 6 (5.0)
Disseminated 2 0 0 2 (1.7)
Central nervous system 0 1 0 1 (0.8)
Gastrointestinal tract 0 0 1 1 (0.8)
All body sites 76 24 19 119 (100)

*MAC, Mycobacterium avium complex; RGM, rapidly growing mycobacteria.

Main Article

Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external